HR 7640 · 117th Congress
To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").
This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Latest action
2022-05-03 — Referred to the House Committee on Energy and Commerce.
Sponsor
Gus BilirakisCosponsors
Cosponsors not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-7640
to populate.
Action history
Action history not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-7640
to populate.
Subjects
Subjects not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-7640
to populate.
Titles
Titles not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-7640
to populate.
Summaries
Summaries not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-7640
to populate.
Vote history
No votes recorded for this bill yet.
Coming in later phases
Committee path (Phase 4)
Committee referrals and reports will appear here.
Search within this bill (Phase 5)
Bill text will become searchable here.